Can the Consideration of Societal Costs Change the Recommendation of Economic Evaluations in the Field of Rare Diseases? An Empirical Analysis

  1. Aranda-Reneo, I.
  2. Rodríguez-Sánchez, B.
  3. Peña-Longobardo, L.M.
  4. Oliva-Moreno, J.
  5. López-Bastida, J.
Zeitschrift:
Value in Health

ISSN: 1524-4733,  1098-3015

Datum der Publikation: 2021

Ausgabe: 24

Nummer: 3

Seiten: 431-442

Art: Rezension

DOI: 10.1016/J.JVAL.2020.10.014 GOOGLE SCHOLAR lock_openOpen Access editor
Datenquelle: Scopus